Nanexa AB

Research Nanexa AB (NANEXA) on Bullrun: market cap SEK 683.71M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerNANEXA
• ExchangeST
• CountrySweden
• SectorHealthcare
• IndustryDrug Manufacturers - Specialty & Generic
• CurrencySEK
• Market capSEK 683.71M
• Financial periodQ4 2025
• RevenueSEK 30.09M
• Net incomeSEK 16.04M
• Free cash flowSEK 12.07M
• Gross margin115.7%

Valuation Snapshot

latest market cap is SEK 683.71M.

About Nanexa AB

Nanexa AB (publ), a pharmaceutical company, develops injectable drug products in the Nordic countries, Europe, Asia, and North America. The company offers PharmaShell, a drug delivery system based on atomic layer deposition coating technology for controlled release of various types of active pharmaceutical substances. It also develops NEX-22, a glucagon-like peptide-1 analogue liraglutide that has completed Phase I trial for the treatment of type 2 diabetes;

Frequently asked questions

What is Nanexa AB's market cap?

Nanexa AB's market capitalization is SEK 683.71M.

What does Nanexa AB do?

Nanexa AB (publ), a pharmaceutical company, develops injectable drug products in the Nordic countries, Europe, Asia, and North America.